{"id":232699,"date":"2026-06-29T00:00:00","date_gmt":"2026-06-29T00:00:00","guid":{"rendered":"http:\/\/clarivate.com\/life-sciences-healthcare\/report\/47041060-medtech-cardiac-assist-devices-market-insights-europe\/"},"modified":"2026-07-21T11:07:20","modified_gmt":"2026-07-21T11:07:20","slug":"48000640-medtech-cardiac-assist-devices-market-insights-europe","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/48000640-medtech-cardiac-assist-devices-market-insights-europe\/","title":{"rendered":"Cardiac Assist Devices &#8211; Market Insights &#8211; Europe"},"content":{"rendered":"<p>The European cardiac assist device market, although encumbered by recurring device recalls, will continue to grow rapidly due to new product development, expanded use across a broader patient population, and favorable reimbursement conditions. Growth will primarily be driven by temporary <abbr data-abbreviation-entity=\"9675\" title=\"Ventricular Assist Device\">VAD<\/abbr>s and the expanding use of cardiac assist devices into historically undertreated patient segments.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the state of the market for cardiac assist devices in Europe from 2019 through 2035.<\/p>\n<p class=\"question-statement\"><strong>Innovative novel devices will play a major role in changing the landscape of the cardiac assist device market.<\/strong><\/p>\n<p class=\"question-statement\">Which device segments are expected to see product innovations?<\/p>\n<p class=\"question-statement\">Which key design features are competitors emphasizing?<\/p>\n<p class=\"question-statement\">How will procedure volumes be affected by emerging products?<\/p>\n<p class=\"question-statement\"><strong>Clinical trials have a strong impact on the cardiac assist device market.<\/strong><\/p>\n<p class=\"question-statement\">Which competitors have early feasibility studies underway?<\/p>\n<p class=\"question-statement\">Which additional indications are expected to receive approval based on positive trial results?<\/p>\n<p class=\"question-statement\">Which competitors are benefiting the most from accumulating clinical evidence?<\/p>\n<p class=\"question-statement\"><strong>The cardiac assist device market will be primarily driven by <abbr data-abbreviation-entity=\"9675\" title=\"Ventricular Assist Device\">VAD<\/abbr> devices.<\/strong><\/p>\n<p class=\"question-statement\">What factors influence the growth of <abbr title=\"Ventricular Assist Device\">VAD<\/abbr> market?<\/p>\n<p class=\"question-statement\">How does the market growth differ for durable and temporary <abbr title=\"Ventricular Assist Device\">VAD<\/abbr>s?<\/p>\n<p class=\"question-statement\">Why are physicians concerned about the recent recalls and lack of competition in the durable <abbr title=\"Ventricular Assist Device\">VAD<\/abbr> market?<\/p>\n<p class=\"question-statement\">What future advancements are anticipated in the durable and temporary <abbr title=\"Ventricular Assist Device\">VAD<\/abbr> markets?<\/p>\n<p><strong>The <abbr data-abbreviation-entity=\"9684\" title=\"Total Artificial Heart\">TAH<\/abbr> market will grow through 2035.<\/strong><\/p>\n<p>How does the usage of <abbr data-abbreviation-entity=\"9684\" title=\"Total Artificial Heart\">TAH<\/abbr> vary across countries?<\/p>\n<p>Who are the emerging players tapping this niche segment?<\/p>\n<p class=\"question-statement\"><strong>The remote hemodynamic monitoring system continues to expand.<\/strong><\/p>\n<p class=\"question-statement\">What factors determine remote hemodynamic monitoring system usage patterns?<\/p>\n<p>What are the major barriers to remote hemodynamic monitoring system adoption, and how will this change going forward?<\/p>\n","protected":false},"template":"","class_list":["post-232699","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-cardiac-assist-devices","medtech-therapy-area-cardiovascular","medtech-geography-europe","medtech-date-2828"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/232699","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=232699"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}